Literature DB >> 18707811

Prevalence of Toxoplasma gondii infection in Belgian house cats.

Stéphane De Craeye1, Aurelie Francart, Julie Chabauty, Veerle De Vriendt, Steven Van Gucht, Ingrid Leroux, Erik Jongert.   

Abstract

Five hundred and sixty seven sera of healthy house cats aged 3 months to 7 years, were examined for the presence of anti-toxoplasma antibodies by indirect immunofluorescence assay and compared to SAG1 and TLA enzyme linked immunosorbent assays as alternative test. Twenty-five percent of cats tested positive for IgG and/or IgM. Seroprevalence increased with age from 2% below 12 months of age up to 44% at age 7. Sensitivities of SAG1 and TLA ELISA were 84.1% and 88.6%, respectively. Peak levels in seroprevalence were correlated to increased IgG titers in TLA ELISA. Our results suggest that T. gondii infections are common in house cats and that there is a high chance for a negative cat to seroconvert in its second life-year.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707811     DOI: 10.1016/j.vetpar.2008.07.001

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Seroprevalence and B1 gene Phylogeny of Toxoplasma gondii of Dogs and Cats in Republic of Korea.

Authors:  Yeojin Park; Jinhyeong Noh; Hyun-Ji Seo; Keun-Ho Kim; Subin Min; Mi-Sun Yoo; Bo-Ram Yun; Jong-Ho Kim; Eun-Jin Choi; Doo-Sung Cheon; Sung-Jong Hong; Soon-Seek Yoon; Yun Sang Cho
Journal:  Korean J Parasitol       Date:  2020-06-26       Impact factor: 1.341

2.  Excretion of Toxoplasma gondii oocysts from Feral Cats in Korea.

Authors:  Kyu-Sung Ahn; Ah-Jin Ahn; Sang-Ik Park; Woon-Mok Sohn; Jae-Han Shim; Sung-Shik Shin
Journal:  Korean J Parasitol       Date:  2019-12-31       Impact factor: 1.341

3.  Prevalence of Toxoplasma gondii infection in household cats in Korea and risk factors.

Authors:  Sung-Hee Hong; Young-Il Jeong; Jae-Young Kim; Shin-Hyeong Cho; Won-Ja Lee; Sang-Eun Lee
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.